Company Overview

Update
Status:
Acquired by AstraZeneca
Founded:
2006
Headquarters:
Redwood City, CA
Funding:
$232M
Categories:
Health and Wellness, Medical, Pharmaceuticals, Biotechnology
Description:
Pearl develops a combination of products for the treatment of respiratory diseases, including chronic obstructive pulmonary disease.

Detailed Description

Update

Pearl Therapeutics is developing unique dual and triple combination products for the treatment of widely prevalent respiratory diseases, including chronic obstructive pulmonary disease.

Pearl's current focus is on making advanced inhaled therapies available to broad patient populations via familiar and accepted metered dose inhalers.

Pearl is a privately held company led by a seasoned team of respiratory product development experts. Pearl aims to offer patients and healthcare providers alternatives that better meet their needs and improve upon the safety and efficacy of existing respiratory therapeutics to achieve better clinical outcomes.

Current Team (1)

Update

Past Team (5)

Update

Board Members and Advisors (1)

Update

Investors (5)

Update

Offices/Locations (1)

Update
  • Corporate Headquarters

    200 Saginaw Drive

    Redwood City, CA 94063

    USA

Images (1)

Update
  • 2df23e95b7f446915047f2f6d8ae0c97